Align Technology Guides Q3 Revenue at $1B-$1.02B
ALGN sits 40% above its 52-week low of $122.
Summary
Align Technology issued Q3 revenue guidance of $1B-$1.02B, a forward-looking range that provides the first official top-line outlook for the quarter. The midpoint of $1.01B represents a modest sequential increase from Q1's reported revenue, suggesting steady demand for Invisalign and iTero products. This guidance arrives amid a busy period for the company, following a recently announced $400M-$500M buyback expansion and the addition of Elliott-backed directors, signaling active capital allocation and governance shifts. The revenue range will be a key benchmark for analysts modeling the impact of the ongoing EU antitrust investigation and recent executive departures. No earnings or margin guidance was provided, leaving profitability assumptions unchanged for now.
At the time of this announcement, ALGN was trading at $171.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.9B. The 52-week trading range was $122.00 to $208.31. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.